MedTrace Logo

Management of Sleep Apnea Patients by a Clinical Nurse (Supernurse)

NCT03455920 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2020-12-10

No results posted yet for this study

Summary

Sleep apnea is a prevalent problem and references for the evaluation of this condition often exceeds the sleep clinic's capacity thus creating important delays in the patients' care.

The overall goal of this project is to assess the feasibility and the non-inferiority of integrating a clinical nurse, or supernurse, to the initial consultation team.

The hypothesis is that the integration of a clinical nurse to the sleep clinic's evaluation team is non inferior in terms of patients' outcomes such as improvement of symptoms and quality of life as well as adherence to treatment.

This study is supported by funding dedicated to teaching and research activities related to sleep-disordered breathing.

Conditions

  • Sleep Apnea Syndromes
  • Sleep Apnea
  • Multidisciplinary Communication
  • Sleep Apnea, Obstructive

Interventions

OTHER

Clinical nurse (supernurse) evaluation

The first evaluation of the patient refered to the sleep clinic will be performed by the clinical nurse then discussed with the pulmonologist in charge.

OTHER

Pulmonologist evaluation

The first evaluation of the patient refered to the sleep clinic will be performed only by the pulmonologist.

Sponsors & Collaborators

  • Laval University

    collaborator OTHER

  • Annie C Lajoie

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-12-19
Primary Completion
2020-04-30
Completion
2020-04-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03455920 on ClinicalTrials.gov